Artal International S.C.A.

Average Profitability
13.83%
Insider Buys Quantity
5
Insider Buys Sum
$433.32M
Insider Sells Quantity
2
Insider Sells Sum
$1.77B

Insider Activity of Artal International S.C.A.

According to the SEC Form 4 filings, Artal International S.C.A., being in a position of

  1. director at CAVA Group, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 14000000 shares for $1.77B,
    over all time since 2024-08-26, has bought 0 shares, and sold 14000000 shares for $1.77B.

The largest purchase of all time was on 2014-11-26 and amounted to 298507462 shares of Lexicon Pharmaceuticals, Inc. for $300M.

The largest sale of all time was on 2024-11-18 and amounted to 8000000 shares of CAVA Group, Inc. for $1.07B.

Biography of Artal International S.C.A.

No biography is available at this moment.

2024-11-18SaleCAVA Group, Inc.
CAVA
director
8M
6.6466%
$134.13$1.07B+2.67%
2024-08-26SaleCAVA Group, Inc.
CAVA
6M
4.3245%
$116.36$698.16M+4.97%
2023-06-05PurchaseLexicon Pharmaceuticals, Inc.
LXRX
27.78M
15.0418%
$2.60$72.22M-32.28%
2020-12-16PurchaseLexicon Pharmaceuticals, Inc.
LXRX
10.94M
9.4404%
$3.20$35M+59.57%
2018-05-29PurchaseScholar Rock Holding Corporation
SRRK
10 percent owner
900,000
7.3781%
$14.00$12.6M+17.37%
2014-11-26PurchaseLexicon Pharmaceuticals, Inc.
LXRX
298.51M
50.5311%
$1.00$300M+12%
2012-10-23PurchaseLexicon Pharmaceuticals, Inc.
LXRX
6M
1.237%
$2.25$13.5M+1.86%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.